Halozyme Appoints Darren Snellgrove as Chief Financial Officer
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/15/2026
- S&P 500 ends higher as traders shift from AI to healthcare
- U.S. producer prices rise by 1.3% month-on-month in September
- Brent steady as US weighs easing sanctions on global 'shadow fleet'
- UBS now expects a third Fed rate hike after hot September inflation print
- Tesla-SpaceX Merger could be announced before December, Barclays says
| Halozyme Therapeutics, Inc. (NASDAQ: HALO) | Delayed: 121.51 +4.69 (4.01%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $116.82 | 52 Week High | $18.39 | |||
| Open | $118.35 | 52 Week Low | $6.96 | |||
| Day High | $122.33 | P/E | N/A | |||
| Day Low | $117.38 | EPS | $-0.58 | |||
| Volume | 2,470,176 | |||||
